The development of hypophosphatemia with ferric carboxymaltose is mediated by the upregulation of fibroblast growth factor 23 (FGF23), which is a phosphaturic hormone produced by osteocytes and a regulator of phosphate homeostasis [15,56,57]. The gene discussed is FGF23; the disease is hypophosphatemia.